MetLife's results for Q3 2026 (quarter ended Sep 30, 2026) come from the company's own earnings release, filed with the SEC on 2026-11-04. Everything below is taken from that filing; quotes are copied exactly. Company outlooks are the company's own.
At a glance
| Item | Value |
|---|---|
| Revenue (GAAP) | $20,522 million (+18.2% vs a year earlier) |
| Diluted EPS (GAAP) | $3.67 |
| Adjusted per-share figure (company's non-GAAP measure; FFO/AFFO for REITs) | $2.78 |
| Full-year guidance | No outlook given |
Guidance
No numeric outlook; MetLife says it is on track to meet its 2026 free cash flow ratio and direct expense ratio targets.
Why this label: EX-99.1 gives no outlook figures; it says only 'On track' for free cash flow ratio and direct expense ratio targets (non-core). Slide VII guidance is not core.
From the release
Revenue: "Total revenues · $ 20,522 · $ 17,361"
Earnings per share: "Net income (loss) per share · $ 3.67 · $ 1.22 · 201%"
Quotes are copied from the filing; in table rows, cell borders are shown as “·”.
Key fact: Adjusted EPS excluding notable items rose 22% to $2.85, a company record.
Source
MetLife earnings release (SEC filing), accession 0001099219-26-000058, filed 2026-11-04.
Part of the Q3 2026 Guidance Tracker. Educational only, not advice. Free weekly recap every Sunday: yieldterminalpro.com/newsletter.